These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23597494)

  • 41. C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
    Watson A; Pribadi M; Chowdari K; Clifton S; Joel Wood ; Miller BL; Coppola G; Nimgaonkar V
    Psychiatry Res; 2016 Jan; 235():200-2. PubMed ID: 26723138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
    Jiang J; Ravits J
    Neurotherapeutics; 2019 Oct; 16(4):1115-1132. PubMed ID: 31667754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis.
    Jang JH; Kwon MJ; Choi WJ; Oh KW; Koh SH; Ki CS; Kim SH
    Neurobiol Aging; 2013 Apr; 34(4):1311.e7-9. PubMed ID: 23088937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of C9orf72 repeat expansion in amyotrophic lateral sclerosis patients from North India.
    Vats A; Gourie-Devi M; Suroliya V; Verma S; Faruq M; Sharma A; Ganguly NK; Kukreti R; Wajid S; Taneja V
    J Neurol Sci; 2017 Feb; 373():55-57. PubMed ID: 28131227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
    DeJesus-Hernandez M; Mackenzie IR; Boeve BF; Boxer AL; Baker M; Rutherford NJ; Nicholson AM; Finch NA; Flynn H; Adamson J; Kouri N; Wojtas A; Sengdy P; Hsiung GY; Karydas A; Seeley WW; Josephs KA; Coppola G; Geschwind DH; Wszolek ZK; Feldman H; Knopman DS; Petersen RC; Miller BL; Dickson DW; Boylan KB; Graff-Radford NR; Rademakers R
    Neuron; 2011 Oct; 72(2):245-56. PubMed ID: 21944778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
    Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
    Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The
    Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):310-316. PubMed ID: 30907153
    [No Abstract]   [Full Text] [Related]  

  • 49. C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
    Braems E; Swinnen B; Van Den Bosch L
    Acta Neuropathol; 2020 Nov; 140(5):625-643. PubMed ID: 32876811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeat expansion in C9ORF72 is not a major cause of amyotrophic lateral sclerosis among Iranian patients.
    Alavi A; Nafissi S; Rohani M; Shahidi G; Zamani B; Shamshiri H; Safari I; Elahi E
    Neurobiol Aging; 2014 Jan; 35(1):267.e1-7. PubMed ID: 23962495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
    Cistaro A; Pagani M; Montuschi A; Calvo A; Moglia C; Canosa A; Restagno G; Brunetti M; Traynor BJ; Nobili F; Carrara G; Fania P; Lopiano L; Valentini MC; Chiò A
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can ALS-associated C9orf72 repeat expansions be diagnosed on a blood DNA test alone?
    Pamphlett R; Cheong PL; Trent RJ; Yu B
    PLoS One; 2013; 8(7):e70007. PubMed ID: 23894576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p.
    Stewart H; Rutherford NJ; Briemberg H; Krieger C; Cashman N; Fabros M; Baker M; Fok A; DeJesus-Hernandez M; Eisen A; Rademakers R; Mackenzie IR
    Acta Neuropathol; 2012 Mar; 123(3):409-17. PubMed ID: 22228244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat.
    Jones AR; Woollacott I; Shatunov A; Cooper-Knock J; Buchman V; Sproviero W; Smith B; Scott KM; Balendra R; Abel O; McGuffin P; Ellis CM; Shaw PJ; Morrison KE; Farmer A; Lewis CM; Leigh PN; Shaw CE; Powell JF; Al-Chalabi A
    Neurobiol Aging; 2013 Sep; 34(9):2234.e1-7. PubMed ID: 23587638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection.
    Shamim U; Ambawat S; Singh J; Thomas A; Pradeep-Chandra-Reddy C; Suroliya V; Uppilli B; Parveen S; Sharma P; Chanchal S; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Keerthipriya M; Mahajan NP; Reddy N; Thomas PT; Sadasivan A; Warrier M; Seth M; Zahra S; Mathur A; Vibha D; Srivastava AK; Nalini A; Faruq M
    Neurobiol Aging; 2020 Apr; 88():156.e1-156.e9. PubMed ID: 32035847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.